Home

MEDICA 2026 · See you in Düsseldorf！

2026-11-10 10:00

Visitor Opening Hours:
Monday – Wednesday: 10:00–18:00
Thursday: 10:00–16:00

In Europe’s medical device market, building trust from the first contact often involves overcoming time zone differences, language barriers, and the back-and-forth of sample shipments.

MEDICA brings months of communication and coordination together in just four days – November 16–19, 2026, in Düsseldorf, Germany.

If you are looking for insulin pump suppliers or potential bussiness parters, MEDICA could be one of the most effcient opportunities of the year to connect.

At MEDICA 2026, AARUY Medical will showcase its complete insulin pump system, including both pumps and consumables, serving users who prefer either patch-type or portable insulin pump solutions. With the same pump body, user can switch between the two configurations simply by changing the corresponding consumables.

Patch-Type Mode: Tubeless and discreet, the patch-type configuration offers greater freedom during daily activities and sleep, without the inconvenience of tubing tangles or pulling. It features a thin, hypoallergenic, medical-grade adhesive patch designed to fit comfortably against the skin without causing a stuffy feeling.

Portable-Type Mode: Available with different tubing lengths, the portable configuration allows the infusion site to be positioned separately from the pump.It is suitable for users who need to rotate infusion sites frequently or whose skin is recobering, helping avoid prolonged on the same area.

AARUY Medical also focuses on engineering details that matter in European clinical settings:

3mL Reservoir: Compatible with standard insulin cartridges. The insulin can be loaded in one step, reducing contamination risks associated with insulin transfer.
Patented Balanced Cannula Design: Optimized to address issues with conventional patch pump cannulas, such as displacement during body movement and potential enlargement of the insertion wound.
Precise Insulin Delivery: A minimum delivery increment of 0.025 U supports the fine insulin dosing needs of children, adolescents, and insulin-sensitive users.